Average Co-Inventor Count = 6.79
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Gilead Sciences, Inc. (3 from 919 patents)
3. Other (1 from 832,680 patents)
19 patents:
1. 11279710 - Processes for preparing ACC inhibitors and solid forms thereof
2. 10815214 - Regioselective N-2 arylation of indazoles
3. 10745412 - Processes for preparing ACC inhibitors and solid forms thereof
4. 10689369 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
5. 10519165 - Processes for preparing ACC inhibitors and solid forms thereof
6. 10435386 - Regioselective N-2 arylation of indazoles
7. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
8. 10287272 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
9. 10275332 - System for interacting with a web visitor
10. 10072025 - Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors
11. 10059705 - Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
12. 9957264 - Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors
13. 9957265 - N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
14. 9725445 - Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors
15. 9580407 - Regioselective N-2 arylation of indazoles